Skip to content

Commit

Permalink
Update to version 3.0.2 since 3.0.1 has previously been used accident…
Browse files Browse the repository at this point in the history
…ially
  • Loading branch information
susannasiebert committed Jul 25, 2016
1 parent 74b1c67 commit b1628ab
Show file tree
Hide file tree
Showing 2 changed files with 2 additions and 2 deletions.
2 changes: 1 addition & 1 deletion README.md
Original file line number Diff line number Diff line change
Expand Up @@ -2,7 +2,7 @@
Cancer immunotherapy has gained significant momentum from recent clinical successes of checkpoint blockade inhibition. Massively parallel sequence analysis suggests a connection between mutational load and response to this class of therapy. Methods to identify which tumor-specific mutant peptides (neoantigens) can elicit anti-tumor T cell immunity are needed to improve predictions of checkpoint therapy response and to identify targets for vaccines and adoptive T cell therapies. Here, we provide a cancer immunotherapy pipeline for the identification of **p**ersonalized **V**ariant **A**ntigens by **C**ancer **Seq**uencing (pVAC-Seq) that integrates tumor mutation and expression data (DNA- and RNA-Seq).
http://www.genomemedicine.com/content/8/1/11

## New in version 3.0.1
## New in version 3.0.2
<ul>
<li>Bugfix: Some allele names in the list of valid alleles were incorrect. The list has been updated.</li>
<li>If the generate_fasta step creates an empty file during the execution of a run the run will terminate early.</li>
Expand Down
2 changes: 1 addition & 1 deletion setup.py
Original file line number Diff line number Diff line change
Expand Up @@ -9,7 +9,7 @@

setup(
name="pvacseq",
version="3.0.1",
version="3.0.2",
packages=["pvacseq", "pvacseq.lib"],
entry_points={
"console_scripts":[
Expand Down

0 comments on commit b1628ab

Please sign in to comment.